
Healthcare access for the next billion
AI-based health information via WhatsApp
B2B infrastructure for rural healthcare partners
Currently in development. First pilot planned for 2027.
I have had a cough and a sore throat for 5 days, and a mild fever.
I understand. Let me ask a few questions to better understand the situation. Do you have any difficulty breathing or chest pain?
No.
Is it getting worse, or about the same?
About the same.
Thank you. Based on what you have shared, please see a doctor ideally within the next day or two. If your condition worsens before that, call 112 or 102 or 108 or go to the nearest hospital.
Illustrative example
See how it works
Doctors exist. They are out of reach.
In rural India, the doctor-to-patient ratio is 1:11,000. Families travel long distances for basic consultations, spending money they can't spare on transport, only to wait hours or be turned away.
Delayed care leads to preventable outcomes. The healthcare system is overwhelmed. Something has to change.
Here's what rural families told us:
"Travel time is a big concern. Money/cost is a huge concern."
"We travel 25-30 km, spend a lot of money, and still often don't meet the doctor because he has already left."
"If such a facility is available at home, it would be very good."
Symtho brings care guidance to you
Instead of traveling long distances and waiting all day, families can describe symptoms by text message on WhatsApp. Symtho helps them find the right next step: seek urgent care now, or see a doctor within the next day or two.
Symtho is an AI health information service that works directly in WhatsApp. No app download, no registration, no payment.
Users describe their symptoms by text in English or Hindi. Our AI asks follow-up questions and gives health information based on established protocols, helping users find the right level of care. Voice is on our roadmap.
60%
definitively said they would use it
40
field interviews in Assam and Uttar Pradesh
How Symtho works
From symptom to the right next step in minutes, not hours or days
Start a chat
Send a WhatsApp message. Works in English and Hindi today, with more Indian languages planned.
AI follow-up
Symtho asks a few short follow-up questions about your symptoms, built on physician developed clinical safety protocols.
Get guidance
Receive clear guidance in plain language: seek urgent care now, or see a doctor within the next day or two.
Connect to care
Get pointed to a care option offered by the healthcare partner, such as a clinic or a teleconsultation.
Start a chat
Send a WhatsApp message. Works in English and Hindi today, with more Indian languages planned.
AI follow-up
Symtho asks a few short follow-up questions about your symptoms, built on physician developed clinical safety protocols.
Get guidance
Receive clear guidance in plain language: seek urgent care now, or see a doctor within the next day or two.
Connect to care
Get pointed to a care option offered by the healthcare partner, such as a clinic or a teleconsultation.
Next-day follow-up: Symtho checks back the next day to see how you're doing.
Symtho is a health information service that helps users find the right next step in care. It does not give a diagnosis or treatment and does not replace a doctor. In an urgent situation, call 112, 102 or 108. Symtho is delivered through licensed healthcare partners.
Why Symtho is different
Built from the ground up for the underserved, not retrofitted for them
No app download
Works inside WhatsApp. Nothing to install, no account to create.
Plain language
Short questions and clear answers in everyday words. Voice for users who cannot read is on our roadmap.
Completely free
Users never pay. Revenue comes from licensed healthcare partners such as hospital groups, insurers and health organisations.
Speaks your language
English and Hindi today, with more Indian languages planned. Built to understand local terminology.
Clinically validated. Built on Indian cases.
492
clinically validated cases
0
urgent cases missed
40
field interviews in Assam and Uttar Pradesh
60%
definitively said they would use it
Zero urgent cases missed across 492 clinically validated cases. The result held through a full system revision. Every case was labelled by our clinical lead against physician developed safety protocols. A deterministic safety layer runs alongside the AI, and the AI cannot override an urgent finding from it. Over 90 percent agreement with clinician-assigned urgency levels across 492 clinically validated cases. Full methodology is available to partners in due diligence.
Your health data stays yours
Minimal personal data
Phone numbers are pseudonymised, and we never ask for names or addresses.
Built for GDPR and DPDP
Designed around European and Indian data protection law from day one.
Encryption
Data is encrypted in transit and at rest.
Partner with us
Symtho is B2B infrastructure for licensed healthcare partners. We don't serve end users directly. Partners deploy Symtho within their existing regulated services to extend reach and improve user experience. Symtho provides the technology layer.
Telemedicine
Telemedicine providers
Users who need to see a doctor are pointed to your service, under your brand.
NGOs & Government
ASHA networks, SHGs, health missions
Offer free health guidance to the communities you serve, under your programme's name.
Hospitals
Hospital groups and clinics
Reach rural patients earlier. People who need a doctor are pointed to your clinics as planned visits, with your brand on the WhatsApp number.
Health insurers
Health and micro insurance
Offer members free health guidance under your brand, with a next-day follow-up that keeps members connected to you.
Microfinance networks
Rural member organisations
Millions of rural members and daily touchpoints. Offer members free, trusted health guidance in Hindi or English, as a service under your brand.
About Symtho
Symtho is being built by a team with experience in scaling digital products, healthcare compliance, and AI development. We've validated our concept through 40 field interviews in rural villages in Assam and Uttar Pradesh, as well as directly at hospital hubs where sick patients seek care, and the response was overwhelming.
We're preparing for a first pilot in 2027.

Jacob Skaaning
Founder & CEO
Entrepreneur based in Copenhagen with a background in compliance, data privacy, and scaling digital products across international markets. Has conducted 40 field interviews in rural India, at village level and directly at hospital hubs, to validate the problem and build a solution grounded in real patient needs. Leads product strategy, partnerships, and go-to-market.
LinkedIn
Group Captain (Dr.) Renuka Garg (Retd), MBBS, MSc
Clinical Lead
Career military physician based in India. Built the clinical safety protocol and the red flag dictionary behind Symtho, and clinically labelled every case in the 492 case validation.
1902 Software
Development partner
Established development house and long term partner. Handles backend architecture, WhatsApp integration and LLM orchestration.
Frequently asked questions
Symtho is provided to licensed healthcare partners, who can offer the service free to their end users. Symtho generates revenue through partnerships with licensed healthcare partners such as hospital groups, insurers and health organisations, not from patients directly.
No. Symtho is a health information service that helps users navigate care options. It does not provide medical diagnosis, treatment, or medical advice. Users should always consult a qualified healthcare provider for any health concerns.
Symtho works in English and Hindi today. Tamil, Telugu, Bengali, Malayalam and Urdu are on the roadmap.
Your phone number is pseudonymised, and we never ask for your name or address. Before you start, the service explains how your data is handled and asks for your consent. You can ask to see, correct or delete your data at any time.
Symtho is in development. A first pilot with a healthcare partner is planned for 2027, and partners will offer the service to their users after that. Sign up above for updates.
Get in touch
Interested in partnering, investing, or just learning more? We'd love to hear from you.